Liang et al.’s research showed that in pancreatic cancer, HES1 is necessary for the oncogenic phenotype mediated by MYEOV; in vitro cell line studies revealed that knockdown of HES1 reduced the migratory and invasive potential of tumor cells overexpressing MYEOV (39). This evidence concerns the gene HES1 and pancreatic neoplasm.